Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
10/30/1991 | EP0454225A1 In-vitro method for amplifying human peripheral blood lymphocytes that produce antigen-specific monoclonal antibodies |
10/30/1991 | EP0454024A2 A process for producing astaxanthin in phaffia rhodozyma |
10/30/1991 | EP0453969A1 Process for production of stranger protein in streptomycetes |
10/30/1991 | EP0453767A1 Improved method for purification of monoclonal antibodies |
10/30/1991 | EP0453563A1 Diagnostic proteins to test for more than one antibody |
10/30/1991 | EP0453561A1 Chimeric mouse human antibodies with specificity to hiv antigens |
10/30/1991 | EP0453560A1 Localization and characterization of the wilms's tumor gene |
10/30/1991 | EP0453556A1 Pneumocystis carinii dihydrofolate reductase gene and methods for its use |
10/30/1991 | EP0453554A1 Chimeric mouse human antibodies with specificity to hiv antigens |
10/30/1991 | EP0453482A1 Biologically active synthetic thyrotropin and cloned gene for producing same |
10/30/1991 | EP0453458A1 Process for the introduction of exogenous dna in somatic and germ animal cells. |
10/30/1991 | EP0429538A4 Plant elongation factor, promoters, coding sequences and uses |
10/29/1991 | US5061788 Elicit immune response against merozoite stage of parasite |
10/29/1991 | US5061625 Process for the preparation of a microorganism which forms α-galactosidase but not invertase, a microorganism thus obtained, and its use |
10/29/1991 | US5061623 Peptides comprising an immunogenic site of poliovirus and dnas containing nucleotide sequences coding for these peptides |
10/29/1991 | CA1340121E Process for amplifying, detecting and/or cloning nucleic acid sequences |
10/29/1991 | CA1291429C Process for amplifying, detecting, and/or cloning nucleic acid sequences |
10/29/1991 | CA1291428C Yeast promoter |
10/29/1991 | CA1291422C Immunometric assay for high molecular weight carcinoembryonic antigen |
10/28/1991 | WO1991017257A1 MONOCLONAL ANTI-IgM ANTIBODIES, THEIR PRODUCTION AND USE, AND HYBRIDOMAS FOR PRODUCING THE SAME |
10/28/1991 | WO1991016928A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
10/28/1991 | WO1991016927A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | WO1991016900A1 Fucosyl transferases involved in adhesion molecule expression |
10/28/1991 | CA2081479A1 Humanized chimeric anti-icam-1 antibodies, methods of preparation and use |
10/28/1991 | CA2081478A1 Humanized cdr-grafted anti-icam-1 antibodies, methods of preparation and usage thereof |
10/28/1991 | CA2079901A1 Monoclonal anti-igm antibodies, their production and use, and hybridomas for producing the same |
10/28/1991 | CA2063244A1 Fucosyl transferases involved in adhesion molecule expression |
10/27/1991 | CA2041213A1 In-vitro method for producing antigen specific human monoclonal antibodies |
10/26/1991 | WO1991016440A1 Dna, dna constructs, cells and plants derived therefrom |
10/26/1991 | CA2081454A1 Dna, dna constructs, cells and plants derived therefrom |
10/26/1991 | CA2040503A1 Selective amplification system using q beta replicase |
10/25/1991 | WO1991016628A1 Purification, detection and methods of use of protease nexin-2 |
10/25/1991 | WO1991016431A1 Soluble, truncated gamma-interferon receptors |
10/25/1991 | CA2081309A1 Soluble, truncated gamma-interferon receptors |
10/25/1991 | CA2079880A1 Purification, detection and methods of use of protease nexin-2 |
10/25/1991 | CA2040649A1 Growth hormone releasing factor analogs |
10/24/1991 | CA2040960A1 Anticoagulant protein and method of production |
10/24/1991 | CA2033666A1 Process for producing astaxanthin in phaffia rhodozyma |
10/23/1991 | EP0453319A1 Alpha-1-acid glycoprotein transgenic mammals |
10/23/1991 | EP0453301A2 Double receptor polynucleotide assay method |
10/23/1991 | EP0453290A2 Nucleic acid probes for the detection of Giardia Lamblia and methods of detection |
10/23/1991 | EP0453242A1 Transfer and expression of gene sequences into central nervous system cells using herpes simplex virus mutants with deletions in genes for viral replication |
10/23/1991 | EP0453216A2 The use of autologous promoters to express gene products in bordetella |
10/23/1991 | EP0453119A1 Modified beta adrenergic receptor |
10/23/1991 | EP0453055A2 Antigenic proteins and vaccines containing them for prevention of coccidiosis |
10/23/1991 | EP0453054A2 Antigenic proteins and vaccines containing them for prevention of coccidiosis |
10/23/1991 | EP0453048A1 Mutated beta-lactam acylase genes |
10/23/1991 | EP0453047A1 Penicillin G acylase, a gene encoding the same and a method for the production of this enzyme |
10/23/1991 | EP0452925A2 Isolated DNA coding for spider silk protein, a replicable vector and a transformed cell containing the isolated DNA, and products thereof |
10/23/1991 | EP0452894A2 Human cells for the high expression of genes inserted in episomal recombinant DNA, their preparation and their use |
10/23/1991 | EP0452849A1 Anti-PP4 monoclonal antibodies, method for production and use thereof |
10/23/1991 | EP0452596A1 Hybridization probes derived from the spacer region between the 16S and 23S rRNA genes for the detection of non-viral microorganisms |
10/23/1991 | EP0452508A1 Mouse antibody v-region gene fragment and preparation of chimera antibody by using said gene fragment |
10/23/1991 | EP0452505A1 M-csf derivative, expression vector of said derivative, product of transformation by said vector, and production of them |
10/23/1991 | EP0452457A1 Method of in vivo delivery of functioning foreign genes. |
10/23/1991 | EP0452433A1 Cytolysis inhibitor proteins (cli) and dna sequences coding for said proteins |
10/23/1991 | EP0452413A1 Generation and selection of novel dna-binding proteins and polypeptides |
10/23/1991 | EP0452391A1 A polypeptide having human monocyte chemotactic factor activity and a dna encoding said polypeptide. |
10/23/1991 | EP0452364A1 Method for preparing water soluble polypeptides |
10/23/1991 | EP0452319A1 Novel protein and coding sequence for detection and differentiation of siv and hiv-2 group of viruses |
10/23/1991 | EP0418230A4 Method for potentiating and inhibiting insulin-like growth factor activity |
10/23/1991 | EP0170697B1 Toxin conjugates |
10/23/1991 | CN1055560A Vectors and compounds for expression of glycosylation mutants of human protein c |
10/23/1991 | CN1014429B Polynucleotide probes |
10/22/1991 | US5059538 Recombinant plasmid inserted with herpes simplex virus gene |
10/22/1991 | US5059534 Rhizobium japonicum 191 NODD-related genes |
10/22/1991 | US5059530 Transforming escherichia coli with plasmid comprising structural gene, a promoter, a DNA fragment with tryptophan terminator, culturing, extracting and purifying |
10/22/1991 | US5059529 Stabilized expression vectors containing λPL promoter and the gene for the cI434 repressor, plasmids containing the vectors, hosts containing the plasmids and related methods |
10/22/1991 | US5059528 Expression of human proapolipoprotein a-i |
10/22/1991 | US5059521 Diagnostic reagent; cancer detection; leukemia; labeling |
10/21/1991 | WO1991016426A1 ENDO-1,4-β-GLUCANASE GENES AND THEIR USE IN PLANTS |
10/21/1991 | CA2401776A1 Plants and tubers expressing patatin and adp-clucose-pyrophosphorylase sequences |
10/21/1991 | CA2040864A1 Alpha-1-acid glycoprotein transgenic mammals |
10/20/1991 | WO1991016429A1 Protein partner screening assays and uses thereof |
10/20/1991 | CA2077439A1 Protein partner screening assays and uses thereof |
10/19/1991 | WO1991017187A2 A 35kD TUMOR ASSOCIATED PROTEIN ANTIGEN: USES AND METHODS OF DETECTION |
10/19/1991 | WO1991016432A1 Modified bacillus thuringiensis insecticidal-crystal protein genes and their expression in plant cells |
10/19/1991 | WO1991016334A1 Erythromycin derivatives |
10/19/1991 | CA2080835A1 A 35kd tumor associated protein antigen and immune complex |
10/19/1991 | CA2080583A1 Erythromycin derivatives |
10/19/1991 | CA2040802A1 Nucleic acid probes for the detection of giardia lamblia |
10/19/1991 | CA2040722A1 Monoclonal antibodies against pp4, processes for the preparation thereof and the use thereof |
10/18/1991 | WO1991016419A1 Methods of tissue implantation |
10/18/1991 | CA2080464A1 Methods of tissue implantation |
10/18/1991 | CA2040566A1 Biosynthesis of proteins in transgenic drosophila |
10/17/1991 | WO1991016348A1 Interleukin-4 binding protein-gamma |
10/17/1991 | WO1991015771A1 Combinations of hepatitis c virus (hcv) antigens for use in immunoassays for anti-hcv antibodies |
10/17/1991 | WO1991015603A1 Enterically transmitted non-a/non-b hepatitis viral agent and characteristic epitopes thereof |
10/17/1991 | WO1991015602A1 Human neuronal nicotinic acetylcholine receptor compositions and methods employing same |
10/17/1991 | WO1991015596A1 Hepatitis c virus protease inhibitors |
10/17/1991 | WO1991015589A1 Improved process of purifying recombinant proteins and compounds useful in such process |
10/17/1991 | WO1991015588A1 Recombinant yeasts containing the dna sequences coding for xylose reductase- and xylitol dehydrogenase enzymes |
10/17/1991 | WO1991015587A1 Self-polymerising expression system based on modified potyvirus coat proteins |
10/17/1991 | WO1991015586A1 Improvements relating to the detection of viruses |
10/17/1991 | WO1991015585A1 Method for the protection of plants against pathogens |
10/17/1991 | WO1991015584A1 Trypanosoma cruzi recombinant antigens and synthetic peptides for utilization in the immunological diagnosis of chagas disease |
10/17/1991 | WO1991015583A1 A protein family related to immediate-early protein expressed by human endothelial cells during differentiation |
10/17/1991 | WO1991015582A2 PURIFIED RAP GAPs, RAP GAP SEQUENCES, AND USES THEREOF |
10/17/1991 | WO1991015581A1 Walk-through mutagenesis |
10/17/1991 | WO1991015580A1 Gene therapy for cell proliferative diseases |